
Medtronic rose 6.8% from $96.28 to $102.86, behind the S&P 500's +13.3%. Its worst day was Jul 14 (−5.1%), and its low came Jun 2 at $73.75.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $1.36 beat the $1.31 estimate on $9.0B revenue (est. $8.9B); FY EPS guidance of $5.62–$5.66 against the $5.64 consensus.
+4.7% · S&P 500 −0.8%
Story events cover the past 12 months · Times ET
EPS of $1.36 beat the $1.33 estimate on $9.0B revenue (est. $8.9B); FY EPS guidance of $5.62–$5.66 against the $5.64 consensus.
−3.1% · S&P 500 +0.2%
EPS of $1.55 beat the $1.55 estimate on $9.8B revenue (est. $9.6B); FY EPS guidance of $5.90–$6.00 against the $6.06 consensus.
+5.7% · S&P 500 −0.7%
Medtronic shares rose 5.0%, while the S&P 500 fell 0.1%.
+5.0% · S&P 500 −0.1%
Medtronic shares fell 5.1%, while the S&P 500 rose 0.4%.
−5.1%, the year's worst day · S&P 500 +0.4%
EPS of $1.45 beat the $1.39 estimate on $9.8B revenue (est. $9.5B); Q2 EPS guidance of $1.32–$1.34 against the $1.35 consensus.
+1.5% · S&P 500 −0.7%
Medtronic shares rose 6.1%, while the S&P 500 rose 1.7%.
+6.1%, the year's best day · S&P 500 +1.7%
Where it ended: a close of $102.86 on Nov 13, 2026. Up next: Q2 2027 earnings on Nov 24, 2026 (EPS est. $1.33, revenue est. $9.5B).
As of the Nov 13, 2026 close
Replay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for MDT and SPY from Benzinga historical bars. Not investment advice.